Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.7 |
mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.7 |
mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |